ARTICLE | Company News
Alza, U.S. Bioscience deal
March 22, 1999 8:00 AM UTC
UBS terminated a 1996 U.S. co-promotion agreement with AZA for UBS's Hexalen altretamine to treat ovarian cancer and NeuTrexin trimetrexate glucuronate to treat moderate to severe Pneumocystis carini...